Podo Mekar Jaya Sentosa is primarily engaged in pharmaceuticals activity. Its headquarters is located in Jawa Timur. The company was founded in 2008. Podo Mekar Jaya Sentosa was established by a group of visionary entrepreneurs with a mission to enhance healthcare accessibility and quality in Indonesia. The company focuses on the development, manufacturing, and distribution of a wide range of pharmaceutical products, including prescription medications, over-the-counter drugs, and health supplements. As a key player in the Indonesian pharmaceutical industry, Podo Mekar Jaya Sentosa has expanded its operations with several branches across major cities in Indonesia, ensuring a robust local geographical footprint. The company is committed to innovation and quality, adhering to international standards in its production processes. Podo Mekar Jaya Sentosa's product portfolio includes well-known brands that cater to various therapeutic areas such as cardiovascular health, diabetes management, and respiratory care. The company is also exploring opportunities in herbal and traditional medicine, aligning with the growing demand for natural health solutions. Internationally, Podo Mekar Jaya Sentosa is gradually expanding its presence, with export markets in Southeast Asia and plans to enter other regions. The company collaborates with global pharmaceutical firms and research institutions to enhance its product offerings and technological capabilities. Podo Mekar Jaya Sentosa is a member of several industry associations, actively participating in initiatives to improve healthcare standards and regulations in Indonesia. The company's vision is to become a leading pharmaceutical provider in the region, driven by a commitment to innovation, quality, and customer satisfaction.
Headquarters
Kota Surabaya Kapasari Genteng Jawa Timur
Surabaya; East Java;
Postal Code: 60273
Contact Details: Purchase the PT Podo Mekar Jaya Sentosa report to view the information.
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service